There is $200B in Global Investment in the Biopharmaceutical Sector Each Year. Who’s Getting It and Why?

11:00 AM - 12:15 PM, Tuesday, June 4, 2019 ・ 115A, Level 100
Attracting even 1% of the $200B annualized global biopharmaceutical investment may translate into $2B of FDI in a highly innovative sector of the economy. How are some governments and policymakers around the world disproportionally attracting and growing their share of international biopharmaceutical investment, while others are failing to attract it or keep it? This panel of experts from government, industry and academia share their experiences and speak in very practical terms about what policies have proven effective in attracting and retaining this high-value add international investment while promoting a strong local research-based biopharmaceutical sector.
Director General, Department of Life Sciences
Ministry of Science and Technology, Taiwan
President and Co-Founder
Center for Medicine in the Public Interest
Associate Vice President, International Policy and Government Affairs
Merck & Co.
Foreign Investment Executive Director in the United States
Deputy Director of the Division of Health Industry Promotion
Ministry of Health and Welfare (MoHW)